REG - Boston Scientific BTG PLC - Confirmation of Stated Post-offer Intentions

Boston ScientificAnnouncement

19/08/2020 14:55

RNS Number : 6156W
  
Boston Scientific Corporation
  
19 August 2020
  
 

THE FOLLOWING ANNOUNCEMENT IS BEING MADE PURSUANT TO THE REQUIREMENTS OF RULE 19.6(C) OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE"), WHICH, INTER ALIA, REQUIRES A PARTY TO AN OFFER TO MAKE AN ANNOUNCEMENT AT THE END OF A PERIOD OF 12 MONTHS FROM THE DATE ON WHICH THE OFFER PERIOD ENDED CONFIRMING WHETHER IT HAS TAKEN, OR NOT TAKEN, THE COURSE OF ACTION SET OUT IN ITS STATED INTENTIONS. 
FOR IMMEDIATE RELEASE
19 August 2020

BRAVO BIDCO LIMITED
an indirect wholly-owned subsidiary of 
Boston Scientific Corporation  
 
Rule 19.6(c) confirmation with respect to stated post-offer intentions with regard to BTG plc (now BTG Limited)
Boston Scientific Corporation ("Boston Scientific") and Bravo Bidco Limited ("Bidco") announce that, further to the completion of Bidco's recommended cash offer for the entire issued and to be issued ordinary share capital of BTG plc (now BTG Limited, "BTG"), which was effected by way of a scheme of arrangement under Part 26 of the Companies Act 2006 on 19 August 2019, Boston Scientific has duly confirmed in writing to The Panel on Takeovers and Mergers in accordance with the requirements of Rule 19.6(c) of the Code that Boston Scientific has complied with its post-offer statements of intent made pursuant to Rules 2.7(c)(iv) and 24.2 of the Code, as originally detailed in the Rule 2.7 announcement of 20 November 2018 and the scheme document published by BTG on 24 January 2019, and as subsequently revised by Bidco's and Boston Scientific's announcement of changes to the stated post-offer intentions with regard to BTG dated 3 April 2020. 
 
Enquiries



Bidco / Boston Scientific
Susie Lisa (Investor Relations)
 


+1 (508) 683-5565



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
OUPUKSURRNUWAAR